Careers  |  Sign In  |  Register  |   Twitter

Faculty
Members

John J. Russell,
MD

Clinical Associate Professor of Family and Community Medicine

Temple University School of Medicine

Philadelphia, Pennsylvania

Director, Family Medicine Residency Program

Abington Memorial Hospital

Abington, Pennsylvania

Robert J. Chilton,
DO

Professor of Medicine

Director of Cardiac Catheterization Labs

University of Texas Health Science Center

San Antonio, Texas

Scott V. Joy,
MD

Medical Director

The Colorado Health Foundation

Visiting Associate Professor of Medicine

The University of Colorado Health System

Denver, Colorado

Louis H. Philipson,
MD, PhD

Professor

Departments of Medicine and Pediatrics

Section of Endocrinology, Diabetes and Metabolism

The University of Chicago

Chicago, Illinois

CME
Front
Matter

Managing the Full Spectrum of Cardiovascular Risk Factors:
A Closer Look at GLP-1 Agonists


CME Information

Estimated Time to Complete Activity

.25 hours per video activity/1 hour for entire four-video series

Publication Date

December 18, 2012

Target Audience

The intended audience for the activities is family physicians and other health care professionals involved in the treatment of patients with type 2 diabetes mellitus.

Faculty for Program
  1. John J. Russell, MD
    Clinical Associate Professor of Family and Community Medicine
    Temple University School of Medicine
    Philadelphia, Pennsylvania
    Director, Family Medicine Residency Program
    Abington Memorial Hospital
    Abington, Pennsylvania
  2. Robert J. Chilton, DO
    Professor of Medicine
    Director of Cardiac Catheterization Labs
    University of Texas Health Science Center
    San Antonio, Texas
  3. Scott V. Joy, MD
    Medical Director
    The Colorado Health Foundation
    Visiting Associate Professor of Medicine
    The University of Colorado Health System
    Denver, Colorado
  4. Louis H. Philipson, MD, PhD
    Professor
    Departments of Medicine and Pediatrics
    Section of Endocrinology, Diabetes and Metabolism
    The University of Chicago
    Chicago, Illinois
Overview of Methods and Participation

Primary care physicians are at the front line in the management of type 2 diabetes, and must therefore be aware of emerging therapies for this disease. During this four video-series, leading clinicians will review the efficacy and safety of available glucagon-like peptide-1 (GLP-1) agonists, namely exenatide, liraglutide, and exenatide extended-release. Special attention will be given to the potential cardiometabolic benefits of these agents. These experts will also review the indications for the use of these agents in combination with insulin. Factors that may improve treatment adherence, such as the use of a pen and the lower frequency of injections with the extended-release formulation, will be evaluated.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation and Accreditation Statements

This enduring material activity, Managing the Full Spectrum of Cardiovascular Risk Factors: A Closer Look at GLP-1 Agonists, has been reviewed and is acceptable for up to 1 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins December 18, 2012. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA/AAFP Equivalency: AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Claiming Credit

To receive up to the maximum of 1.0 AMA PRA Category 1 Credit™, you must view each of the videos, complete each test associated with the video, achieve a score of 75% or higher on each test, and complete an evaluation form. You will then be able to print out your CME certificate.

Technical Requirements
  • A broadband internet connection
  • Operating system: Microsoft Windows XP or later; Mac OS X 10.4 or later; iOS 5.0 or later
  • Web browser: Microsoft Internet Explorer 7.0 or later; Mozilla Firefox; Google Chrome; Apple Safari; Apple Mobile Safari
  • Adobe Flash Player 9.0 or later (Available at: get.adobe.com/flashplayer/), if running on desktop
Learning Objectives

Upon successful completion of the activities, participants will be able to:

  1. Examine the potential utility of GLP-1 agonists in reducing cardiometabolic risk factors in patients with type 2 diabetes.
  2. Discuss the combined use of GLP-1 agonist therapy and insulin to improve glycemia, and aid in the reduction of A1C, weight, and insulin requirements.
  3. Assess the use of longer acting GLP-1 agonists for their ability to achieve A1C targets, and minimize adverse events such as weight gain and hypoglycemia that may affect adherence to therapy.
Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Acknowledgement Statements

This continuing medical education activity is sponsored by:
Vindico Medical Education


This activity is supported by an independent educational grant from:
Amylin Pharmaceuticals, Inc.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

Faculty

Each faculty member has provided the following disclosure information, which is accurate at the time of printing.

  • Robert J. Chilton, DO has a relationship identified with: Consulting Fees – Amylin Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline, Merck Sharp & Dohme, and Takeda.
  • Scott V. Joy, MD has a relationship identified with: Consulting Fees – Lilly and Janssen.
  • Louis H. Philipson, MD, PhD has a relationship identified with: Consulting Fees – Takeda; Contracted Research – Novo Nordisk, Lilly/Amylin, Merck and Takeda.
  • John J. Russell, MD has a relationship with: Fees for Non-CME Services Received Directly from Commercial Interest – Sanofi Pasteur.
Peer Reviewer
  • Mark Schutta, MD has a relationship identified with: Salary – Spouse is a director at Merck; Ownership Interest – Spouse owns stock options at Merck.
Vindico Medical Education Staff

The planning and review staff of Vindico Medical Education has nothing to disclose.

BetterCME Staff

The medical director and production staff of BetterCME have nothing to disclose.

Disclaimer – Vindico Medical Education

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Disclaimer – Patient Management

This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Copyright Statement

© All documents and videos accessed from this page are viewed as a resource of Vindico Medical Education©, all rights reserved and BetterCME©, all rights reserved.